Sullivan & Cromwell Opens Office in ADGM

Sullivan & Cromwell Opens Office in ADGM

Ahmed T. el-Gaili Rejoins as a Partner to Lead the Firm’s Expansion into the Middle East

ABU DHABI, UAE, Sept. 14, 2026 /PRNewswire/ — Sullivan & Cromwell LLP today announced the opening of an office in Abu Dhabi, reinforcing its long-term commitment to the Middle East. Located in ADGM, the international financial center in Abu Dhabi, the capital of the United Arab Emirates, the new office will enhance S&C’s ability to serve clients in the UAE, Saudi Arabia and across the region with its integrated offering, which combines financing, regulatory, and transactional expertise with deep experience working on complex, cross-border, and large-scale mandates.  Ahmed T. el-Gaili will rejoin the firm as a partner to lead the firm’s Middle East practice.

“We are delighted to deepen S&C’s connection to one of the world’s most dynamic financial centers with a new office in Abu Dhabi,” said Robert Giuffra and Scott Miller, Co-Chairs of Sullivan & Cromwell. “Underscoring our long-term commitment to the region, we are pleased to welcome back Ahmed to S&C. He is an outstanding lawyer who is ideally placed to lead our work in the Middle East as we build on the longstanding relationships and track record we have developed advising our clients on their most critical matters across the region.”

Mr. el-Gaili previously practiced at Sullivan & Cromwell for six years in London before relocating to the Middle East. He has nearly two decades of experience in the region advising sovereign wealth funds, state-owned enterprises, governments, leading regional and international corporates, and private equity firms on complex, cross-border transactions and projects. His practice spans M&A, private equity, joint ventures, project finance and development and restructuring, with a particular focus on the energy, infrastructure, life sciences, telecom and technology sectors. He has extensive relationships with leading sovereign wealth funds and state-owned enterprises throughout the Middle East.

“Sovereign capital, private equity and infrastructure investment in the Middle East is fueling some of the most high-profile and complex transactions anywhere in the world, particularly in Saudi Arabia and the UAE,” said Mr. el-Gaili. “S&C’s global platform, integrated offering and depth of expertise make it uniquely positioned to advise the region’s most sophisticated clients on matters where judgment is decisive. I’m delighted to return to S&C and look forward to working with my colleagues across the firm to build our presence in the Middle East at a time of significant activity and growth.”

“We welcome Sullivan & Cromwell to ADGM, the international financial centre of Abu Dhabi, and are pleased to see a leading global law firm establish a presence in our jurisdiction,” said Arvind Ramamurthy, Chief Market Development Officer of ADGM. “Their decision to open an office in ADGM reflects the continued growth of Abu Dhabi as a leading hub for international finance, investment and professional services, and further strengthens the depth of expertise available to regional and global clients operating from ADGM.”

S&C’s expansion into the Middle East will be supported by other firm partners with deep regional experience. Mr. el-Gaili will work closely alongside the wider S&C team, including partner Garth Bray, who brings extensive expertise working on complex cross-border M&A as well as technology and regulatory matters, and Umberto Hassan, whose expertise includes cross-border M&A and complex restructuring, with a focus on clients based in the UAE.

S&C has received full regulatory authorization from ADGM’s Registration Authority.

About Sullivan & Cromwell LLP

Sullivan & Cromwell LLP is a leading global law firm that advises on major domestic and cross-border M&A, significant litigation and corporate investigations, finance and corporate transactions, and complex antitrust, regulatory, tax and estate planning matters. Our Firm’s hallmarks are the highest-quality independent advice and intense dedication to solving client problems. Founded in 1879, S&C has approximately 1,000 lawyers located in offices in New York, Washington, D.C., Los Angeles, Palo Alto, London, Frankfurt, Paris, Brussels, Hong Kong, Beijing, Tokyo, Melbourne, Sydney and Abu Dhabi.

View original content:https://www.prnewswire.co.uk/news-releases/sullivan–cromwell-opens-office-in-adgm-302877913.html

CATL Launches TECTRANS II at IAA Transportation 2026 to Accelerate Global Commercial Vehicle Electrification

HANOVER, Germany, Sept. 14, 2026 /PRNewswire/ — Contemporary Amperex Technology Co., Limited (CATL) today unveiled TECTRANS II, its next-generation commercial vehicle battery solution, at IAA Transportation 2026 in Hanover.

“Commercial vehicle electrification is emerging as the third wave of the global energy transition,” said Akin Li, Executive President of CATL Overseas Business. “Across products, energy, services and ecosystem, CATL is poised to work with partners around the world to catch this third wave.”

TECTRANS II: A Modular Platform Built for Commercial Vehicle Electrification

Scenario Adaptability: Designed for diverse commercial vehicle applications and operating requirements.

• One platform for multiple scenarios: By configuring different numbers of standardized battery packs, TECTRANS II can meet different energy capacity and payload requirements and support a maximum driving range of up to 1,000 kilometers.
• Flexible technology routes: The platform is compatible with both e-axle and central-drive architectures and supports flexible switching between charging and battery swapping.
• One Configuration, Lifetime Compatibility: The platform standardizes external dimensions, electrical interfaces and communication protocols while allowing battery technologies and pack designs to evolve. This enables both new and existing vehicle models to benefit from future upgrades without major changes to the vehicle platform.
• The modular design helps OEMs shorten vehicle development cycles by 50% and reduce R&D costs by 60% to 70%, supporting faster model launches and lower adaptation costs.

Lifecycle Economics: Designed to deliver stronger economics across the entire vehicle lifecycle.

• Faster payback: The modular platform eliminates the need to develop dedicated battery systems for each vehicle model, helping OEMs reduce development costs, shorten launch timelines and lower early-stage investment risk.
• Higher operating returns: TECTRANS II improves fleet economics in three ways.
  • Higher energy density: Boasting a gravimetric energy density of 170 Wh/kg, around 13% above the industry average, the battery enables vehicles to carry approximately 0.6 tonnes of additional payload at the same battery capacity.
  • Longer Range, Faster Charging: Its maximum configuration offers up to 1,000 km of range and 80% charging in 25 minutes with megawatt-level fast charging, minimizing downtime on long-haul routes.
  • Higher energy efficiency: The world’s first full-tab low-impedance design enables 96% system round-trip efficiency (RTE), reducing charging losses and delivering more usable energy for daily operations.
• Stronger residual value: The TECTRANS II battery for heavy-duty trucks is engineered for a 12-year, 1.5-million-kilometer service life with 70% capacity retention, helping support stronger residual value for fleet assets.

Safety and Reliability: Built to withstand real-world commercial operations.

• Robust physical protection:

• • Hot-formed steel upper cover: Withstands repeated stepping by an 180-kilogram adult 10,000 times without deformation.
  • Ultra-strong bottom plate: Delivers 1,000 J impact resistance to protect the battery pack from road impacts.
  • High-strength enclosure protection: Uses an extruded-aluminum enclosure with crush-resistant ribs, delivering lateral crush strength up to 250 kN.
  • 15-year corrosion resistance: Supports long-term operation in coastal environments and cold regions.
  • Maintenance-friendly design: Maintains IPXXB protection with the main connectors connected or disconnected, enhancing high-voltage safety during maintenance.

• System redundancy:

• • Architecture redundancy: Multi-branch independent BMS control enables the system to isolate a failed branch while the remaining branches continue to supply power.
  • Precise fault diagnosis: Proprietary insulation fault-location technology can distinguish whether an insulation issue comes from the battery or other vehicle components, enabling faster troubleshooting.
  • Cybersecurity protection: Multi-layer protection from chip hardware and software programs to the vehicle system, following international information security standards throughout development.

TECTRANS II reflects CATL’s long-term commitment to continuous innovation and consistent product quality. In addition, backed by real-world operating experience and rigorous validation, including full-vehicle torsion and external fire testing, the platform is designed for safety, reliability and long service life in demanding commercial vehicle operations.

Partnering to Build Green Freight Corridors Across Europe

At the show, CATL also signed an MoU with DHL Group. Building on the pair’s September 2024 agreement, the MoU will see the two companies develop Green Freight Corridors across Europe. The partners will leverage DHL’s logistics network, operational expertise and real-world transport requirements alongside CATL’s battery technology and electrification ecosystem. They will also work with OEMs and other partners to co-develop purpose-built electric vehicles and launch pilot deployments.

“Commercial vehicle electrification will unfold over more than a decade,” said Zhu Lingbo, CTO of CATL Global Business Unit. “With our deep technological expertise and long-term commitment, CATL is ready to be the most reliable partner for customers worldwide and for the global electrification of freight transport.”

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/catl-launches-tectrans-ii-at-iaa-transportation-2026-to-accelerate-global-commercial-vehicle-electrification-302877817.html

Dr. Bhargav Mallappa’s New Book on India’s Transformation Released

Sulthan Bathery, Wayanad | 14 September 2026

The book “The Modi Era: India’s Journey of Transformation”, authored by Dr. Bhargav Mallappa, Author and Founder, Akhila Sevak Samaj Council (ASSC), was launched in Sulthan Bathery, Wayanad, on Monday as part of the Birthday Week Celebrations of Hon’ble Prime Minister Shri Narendra Modi Ji.

The event was held at Adithara Auditorium, Sulthan Bathery, in the presence of spiritual leaders, public representatives, social leaders, academics, workers’ representatives and members of the media.

The book seeks to document a period of change in India and encourage discussion on where the country has come from, where it stands today and where it can go in the years ahead. Dr. Mallappa said the book was developed through months of reading, observation and reflection, and that its launch marked the beginning of a wider conversation.

The welcome address was delivered by Dr. S. Selvaganesh, National Chairman, Bharathiya Hindu Parivar and Member, Zonal Railway Users Consultative Committee (ZRUCC), Ministry of Railways, Government of India.

The book was launched in the presence of Madurai Aadheenam Srimath Vishwalinga Thambiran, Thiru Rajasekar Swamigal, Thavathiru Palani Adigalar, Mahaa Shri Shri Yukteshwara Paramacharya Swamigal, Shri Karan Bhushan Singh, Hon’ble Member of Parliament (Lok Sabha), Shri T. S. Srivatsa, Hon’ble MLA, Krishnaraja Constituency, Mysuru, Shri Satyendra Kumar Bari, Member, State Commission for Backward Classes, Uttar Pradesh, Prasanth Malavayal, BJP District President, Wayanad, Dr. Subbha Somu, Shri Chandan Kumar, Dr. Mahalakshmi, and Kaleem Bharathi, among other dignitaries.

Dr. Mallappa said he hoped readers would engage with the ideas in the book, agree with some, question others and develop their own understanding of India’s transformation. He also expressed the hope that the book would become part of conversations among young people, communities, institutions and readers across the country.

The programme concluded with the vote of thanks delivered by Shri Manoj Sharma.

The event was organised by the Akhila Sevak Samaj Council (ASSC) as part of the Birthday Week Celebrations of Prime Minister Narendra Modi.

SleepRes Receives Frost & Sullivan’s 2026 North America New Product Innovation Recognition for Excellence in Positive Airway Pressure Device Innovation

Advancing patient-centric innovation and next-generation therapy delivery in positive airway pressure devices through clinically validated multi-mode technology and enhanced comfort performance

SAN ANTONIO, Sept. 14, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that SleepRes has been recognized with the 2026 North America New Product Innovation Recognition in the Positive Airway Pressure Devices industry for its outstanding achievements in product innovation, clinical differentiation, and patient-centric therapy design. This recognition highlights SleepRes’ leadership in advancing measurable clinical outcomes, and redefining comfort-driven innovation within an evolving sleep therapy landscape.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. SleepRes excelled in both, demonstrating its ability to align innovation with evolving clinical and market requirements while executing with precision, scalability, and regulatory alignment. “The Kricket PAP device supports KPAP, traditional CPAP, and APAP modes within a single platform. This multi-mode architecture enables seamless clinician adoption without forcing protocol changes and aligns with existing reimbursement and prescribing frameworks,” said Utkarsha Soundankar, Industry Analyst, Frost & Sullivan.

Guided by a long-term innovation strategy centered on clinical validation, physician-led design, and platform flexibility, SleepRes has demonstrated strong adaptability in a rapidly evolving Positive Airway Pressure (PAP) market. The company’s strategic focus on integrating algorithmic intelligence with established clinical workflows has enabled efficient excitement across healthcare settings while supporting continuity of care and reimbursement alignment.

Innovation remains central to SleepRes’ approach. Its flagship Kricket™, powered by KPAP™, introduces a differentiated PAP therapy experience that dynamically adjusts pressure delivery in real time, aligning with patient respiration to improve comfort without compromising therapeutic efficacy. “We’re honored to receive this recognition from Frost & Sullivan. It validates our belief that sleep therapy can be both clinically effective and significantly more comfortable for patients, and we’re proud to bring that vision to market.” – John Lipman, CEO at SleepRes.

Frost & Sullivan commends SleepRes for setting a high standard in product innovation, clinical integration, and patient-centric design within the Positive Airway Pressure Devices industry. The company’s vision, supported by FDA 510(k) clearance and a strong clinical foundation, is shaping the future of sleep therapy by enabling more natural, effective, and scalable treatment experiences.

Each year, Frost & Sullivan presents the New Product Innovation Recognition to a company that demonstrates outstanding development and implementation, resulting in measurable improvements in market impact, product differentiation, and competitive positioning. The recognition honors forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.

Contact us: Start the discussion.

Contact:

Ashley Shreve

E: ashley.weinkauf@frost.com 

About SleepRes, Inc.

SleepRes is a sleep and respiratory health technology company dedicated to transforming the treatment of obstructive sleep apnea through thoughtful design, advanced engineering, and patient-first innovation. Powered by its proprietary KPAP™ technology, Kricket™ is building a new generation of sleep therapy solutions that prioritize comfort, and long-term health outcomes.

For more information, visit www.kricket.com.

View original content:https://www.prnewswire.co.uk/news-releases/sleepres-receives-frost–sullivans-2026-north-america-new-product-innovation-recognition-for-excellence-in-positive-airway-pressure-device-innovation-302837166.html

Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research

Strategic move strengthens Cellebrite’s flagship access, extraction and decoding technology as Cellebrite Labs joins Wade’s Innovation Hub

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 14, 2026 /PRNewswire/ — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered digital investigative and intelligence solutions, today announced expanded resources and new leadership for Cellebrite Labs, the team responsible for much of the core mobile research behind the company’s access, extraction and decoding technology. Effective immediately, Cellebrite Labs is operating under the leadership of Chris Wade, Cellebrite’s Chief Technology Officer, and is now part of the company’s Innovation Hub that Wade has led since joining Cellebrite, following its acquisition of Corellium.

The ability to access the broadest range of mobile devices and rapidly convert extracted data into digital evidence and actionable intelligence is central to Cellebrite’s leadership in digital investigations. As mobile security grows more sophisticated and challenging, Cellebrite is committing additional infrastructure, AI resources, research tools and talent to help Cellebrite Labs maintain its leadership across operating systems as the technical environment continues to rapidly evolve.

“Cellebrite’s trusted, innovative digital forensics expertise is at the heart of what makes Cellebrite the trusted partner for digital investigative practitioners around the world, and Cellebrite Labs is where much of that capability is created,” said Cellebrite Chief Executive Officer Shiv Ramji. “Giving Labs dedicated leadership from Chris, a world-renowned expert in mobile vulnerability research and backed by greater resources and investment, will help sharpen our focus and accelerate our speed at exactly the moment the mobile security landscape demands it.”

The Innovation Hub, which Wade leads, brings together focused efforts in high-impact AI research, hardware and software technology initiatives across Cellebrite. Adding Labs to the Hub will concentrate expertise and resources around the capabilities that strengthen Cellebrite’s core business and create new opportunities for growth.

“Cellebrite Labs does some of the most technically demanding work in the company, and it deserves a level of focus and investment to match,” said Chris Wade, chief technology officer at Cellebrite. “I’m looking forward to working closely with the Labs team, and with our Product and Technology organization, to turn that research into capabilities our customers continue to rely on.”

Wade and Ramji will both join an investor Virtual Fireside Chat today, Monday, September 14 at 4:15 p.m. Details include:

About Cellebrite

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

Media 

Jackie Labrecque

Director, PR and Executive Communications

jackie.labrecque@cellebrite.com  

+1 771.241.7010

Investors Relations

Andrew Kramer

Vice President, Investor Relations & Treasury

investors@cellebrite.com

+1 973.206.7760

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-cto-chris-wade-to-lead-cellebrite-labs-sharpening-focus-on-mobile-research-302877212.html

GSME Joined TSMC OIP Value Chain Alliance in North America

Accelerating seamless growth and advanced silicon design innovation from prototype to high-volume production, powered by design services, manufacturing services and AI-driven platform for end-to-end visibility

SAN JOSE, Calif., Sept. 14, 2026 /PRNewswire/ — GS Microelectronics U.S., Inc. (GSME), a leading semiconductor solutions provider, today announced it has officially joined TSMC’s Open Innovation Platform^® (OIP) Value Chain Alliance (VCA) as a member partner in North America. This partnership builds upon GSME’s proven track record of integrating design enablement building blocks with solutions from the OIP Ecosystem partners and delivering comprehensive ASIC services across the entire IC value chain – spanning IP development, front-end architecture, back-end physical design, wafer manufacturing, advanced packaging, assembly, and testing.

The collaboration with TSMC comes during a period of rapid international scaling for GSME. Founded in 2022, the company has grown from a Silicon Valley startup into a global operation in San Jose, Phoenix, Hsinchu, Ho Chi Minh City, Danang, and Muscat. Backed by Series B funding from Maverick Silicon, GSME continues to scale its design services, advanced packaging, IP portfolio, and AI-driven supply chain capabilities.

“Joining TSMC’s OIP ecosystem as a VCA partner in North America underscores our commitment to delivering a unified, execution‑driven platform for our customers,” said Farhat Jahangir, President and CEO of GSME. “Our mission is to give customers a tightly integrated and lower‑risk path from early MPW exploration straight into high‑volume production with end-to-end visibility, eliminating the cost, delay, and fragmentation that come from handing designs across multiple vendors.”

“TSMC is pleased to welcome GSME as an OIP Value Chain Alliance partner in North America,” said Percy Chang, Director of Emerging Business Development at TSMC. “By combining TSMC’s advanced process and packaging technologies with GSME’s design and turnkey services, we are strengthening our OIP ecosystem and expanding the support available to our mutual customers as they develop innovative silicon solutions.”

GSME’s Value-Added Services

Unlike traditional semiconductor service providers that focus on isolated stages of the value chain, GSME supports customers across the full silicon lifecycle through a unified set of capabilities.

The company’s accessible MPW services offer a low-risk entry point for early silicon validation that transitions seamlessly into turnkey high-volume manufacturing, accelerating time-to-market. Backed by end-to-end design expertise in front-end architecture, back-end implementation, quality assurance, and technology incubation, GSME is also actively developing 2.5D/3D advanced packaging capabilities, including support for TSMC CoWoS^®-based architectures to serve AI, and HPC verticals. This entire lifecycle is tied together by GSME’s agentic LLM platform, which provides customers with integrated supply chain visibility from wafer, assembly, to yield.

About GSME

GS Microelectronics U.S., Inc. (GSME) is a leading semiconductor solutions provider headquartered in San Jose, California, with a global presence in Taiwan, Vietnam, and Oman. GSME delivers tailored silicon solutions by leveraging cutting-edge technology and proven domain expertise. The company offers end-to-end chip design, full turnkey manufacturing, quality assurance & reliability, product sustaining, continuous improvement plan (CIP), and strategic incubation services, enabling customers to accelerate innovative products and rapidly scale to market.

Contact:

GSME Press Relations

pressrelations@gsme.com

www.gsme.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/gsme-joined-tsmc-oip-value-chain-alliance-in-north-america-302876870.html

Temporal Raises $550 Million in Series E Round: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, Sept. 14, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on September 14th

• Temporal boosts its valuation to $12.55 billion.
  • The company says its annualized run rate has grown more than 200% year-over-year.
  • Co-founder and CEO Samar Abbas will join NYSE Live to discuss how his company will deploy the fresh funding.
• The RTW Institute celebrates its official launch today.
  • The think tank focuses on strengthening the systems that turn scientific discovery into accessible, life-saving medicines.
  • Chairman Dr. Roderick Wong and CEO Dr. Kinnari Patel will join NYSE Live to share more details about the launch.
• The Rise Fashion Show takes place tonight at the NYSE.
  • The event, in partnership with e.l.f. Beauty (NYSE: ELF), takes place during New York Fashion Week in support of gender-based violence survivors.
• Investors await Wednesday’s Fed decision on interest rates.
  • AI industry leaders called to slow down the pace of development of AI capabilities.
  • As of 8:00 AM ET, there is growing expectation for the Fed to raise interest rates when policymakers meet this week.

Opening Bell

FirstBank (NYSE: FBK) celebrates its 120^th anniversary of founding

Closing Bell

Teva (NYSE: TEVA) celebrates its direct listing and trading on the NYSE

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App and check out the NYSE YouTube: TV.NYSE.com and YouTube.com/@NYSEofficial

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/temporal-raises-550-million-in-series-e-round-nyse-content-update-302877677.html

Miral Invests AED 12 billion to Shape the Next Phase of Yas Island’s Growth

A robust five-year pipeline of new developments and enhancements will expand world-class attractions, grow hotel capacity, and further strengthen Yas Island’s global appeal

ABU DHABI, UAE, Sept. 14, 2026 /PRNewswire/ — Miral, Abu Dhabi’s leading creator of immersive destinations and experiences, will be investing more than AED 12 billion across Yas Island over the next five years. The substantial investment will support a pipeline of new developments alongside expansions and enhancements to existing attractions, reinforcing Miral’s commitment to Abu Dhabi’s Tourism Strategy 2030 and further strengthening Yas Island’s position as a leading global destination for leisure and entertainment.

To view the Multimedia News Release, please click:  

https://www.multivu.com/miral/9421351-en-miral-invests-aed-12-billion-next-phase-yas-islands-growth

This next phase of development reflects a clear focus on expanding Yas Island’s existing world-class theme parks and attractions, as well as introducing new immersive rides and experiences, that respond to evolving visitor expectations. The investment will also grow the island’s hospitality offering, adding new hotel rooms and elevating its accommodation portfolio.

H.E. Mohamed Khalifa Al Mubarak, Chairman of Miral, said, “This investment reflects our commitment to Abu Dhabi’s long-term vision and our ambition to continue shaping one of the world’s most dynamic tourism destinations. Yas Island has become a global success story, demonstrating how world class experiences contribute to economic growth, enhance quality of life, and strengthen Abu Dhabi’s appeal to audiences from around the world.

Over the next five years, this investment will build on that momentum, introducing new experiences and expanding our hospitality and leisure offering to meet our evolving visitor expectations. As Abu Dhabi continues to strengthen its position as a global center for tourism and entertainment, we remain focused on creating lasting value for residents, visitors and future generations, while contributing to the emirate’s sustainable growth and diversification ambitions.”

The AED 12 billion investment, separate from the previously announced Disney project, marks an important step in shaping the long-term growth of Yas Island, building on its established appeal and continuing to enhance its diversity of experiences.

These projects are designed to further enrich the visitor experience, while also supporting job creation and skills development within the tourism sector, thereby fostering a vibrant and future-ready economy for the emirate.

This investment demonstrates Miral’s continued ambition to shape the future of leisure and entertainment in Abu Dhabi and the region, signaling the evolution of Yas Island’s world-class attractions and experiences that will captivate and delight visitors from around the globe for generations to come.

For more information, visit www.miral.ae      

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/miral-invests-aed-12-billion-to-shape-the-next-phase-of-yas-islands-growth-302877701.html

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

• Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
• Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
• Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users.

MILFORD, Mass., Sept. 14, 2026 /PRNewswire/ — Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading standardization and ease-of-use features, making the power of advanced flow cytometry more accessible to researchers in academia and pharmaceutical settings, as well as in contract research organization (CRO) labs.

The new cell analyzer expands Waters’ category-defining FACSDiscover platform of flow cytometers, incorporating the same cutting-edge BD SpectralFX Technology present in the flagship BD FACSDiscover A8 Cell Analyzer, which supports up to five lasers and 78 fluorescence detectors to maximize the palette of colors. This technology enables scientists to analyze more than 50 characteristics of a single cell with consistent, high-quality data.

Together with FACSTruQ Technology, a notable product innovation that delivers next-generation instrument calibration with automated setup and quality control, the cell analyzer provides data consistency across instruments, users, and sites, achieving highly reproducible results with a less than 10% coefficient of variation across a palette of more than 50 dyes.¹ Paired with the BD FACSChorus Software’s guided workflows and the integrated autoloader, the FACSDiscover A7 Cell Analyzer sets a new standard for experimental standardization in flow cytometry.

“The FACSDiscover A7 Cell Analyzer lowers the barrier to advanced spectral flow cytometry and will open up new possibilities for immunology research, enabling our core facility to help scientists uncover deeper biological insights with greater standardization and confidence,” said Cheryl Kim, Senior Director, Flow Cytometry Core, La Jolla Institute for Immunology. “We look forward to the FACSDiscover A7 Cell Analyzer being an integral instrument for our core, allowing our researchers to get the most out of spectral data to advance our important work of improving human health through the development of treatments and cures for immune system disorders.”

Steve Conly, Senior Vice President, Waters Biosciences, Waters Corporation, added, “The FACSDiscover A7 Cell Analyzer couples advanced spectral performance and leading standardization with a compelling price-to-performance balance, bringing spectral flow cytometry within reach of more researchers than ever before, for applications from biomarker discovery to drug development. Just two years after the world’s very first 50-color flow cytometry panel was developed on the BD FACSDiscover™ S8 Cell Sorter,² the FACSDiscover A7 Cell Analyzer extends these transformative capabilities, helping labs meet their increasingly critical needs for reproducibility within our connected ecosystem of instruments, reagents, and informatics.”

The FACSDiscover A7 Cell Analyzer is now commercially available globally and available to order through local representatives. For more information, please visit waters.com and bdbiosciences.com/A7.

BD is a trademark of Becton, Dickinson and Company. Waters is a trademark of Waters Corporation or its affiliates.  All other marks are the property of their respective owners.

About Waters Corporation:

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.

Disclaimer:

The BD Biosciences and BD Diagnostic Solutions businesses have been acquired by Waters Corporation (“Waters”). Becton, Dickinson and Company or one of its affiliates or subsidiaries (“BD”) remains the legal manufacturer of Biosciences and Diagnostic Solutions products until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under BD’s regulatory authority. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary: www.waters.com/bdtransaction.

References:

1) Internal Waters data comparing the BD FACSDiscover™ A7 Cell Analyzer with the BD FACSLyric™ Flow Cytometry System and publicly available data for comparable instruments.

2) Konecny AJ, Mage PL, Tyznik AJ, Prlic M and Mair F. OMIP-102: 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. Cytometry Part A 2024; 105:430-436. DOI: 10.1002/cyto.a.24841

Contact:

Molly Gluck

Head of External Communications

Waters Corporation

+1.508.498.9732

molly_gluck@waters.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/waters-sets-benchmark-for-standardized-spectral-flow-cytometry-with-commercial-launch-of-bd-facsdiscover-a7-cell-analyzer-302877244.html

Cellebrite Initiates Plans to Redomicile in the United States

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 14, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, announced today that the Company’s Board of Directors has authorized Cellebrite to pursue a corporate reorganization, establishing a new United States corporation as the ultimate parent company, subject to shareholder and regulatory approvals.

Shiv Ramji, Cellebrite’s chief executive officer, said, “Redomiciling is a strategic evolution of our company structure. We believe redomiciling in the U.S. will better position us to drive growth across our key customer segments in our largest geographic market as well as with other large government customers outside of the U.S. Redomiciling will also increase Cellebrite’s appeal across a broader investor pool through inclusion in key indices.”

Cellebrite anticipates that the redomiciling will be completed by the first half of 2027, pending successful shareholder and regulatory approvals. Cellebrite plans to share additional details in the coming months, including those related to a special general meeting of shareholders, through additional filings with the U.S. Securities and Exchange Commission.

Caution Regarding Forward Looking Statements

This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include, but are not limited to, the anticipated timeframe for completing the redomiciling and the anticipated benefits from redomiciling such as it will better position us to drive growth across our key customer segments in our largest geographic market as well as with other large government customers outside of the U.S and that it will increase Cellebrite’s appeal across a broader investor pool through inclusion in key indices. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and challenges and evolving industry standards with respect to software, artificial intelligence, or device access, to adapt to changing market potential within our markets and to successfully launch new solutions and add-ons that meet or exceed customer needs; our material dependence on the acceptance of our solutions by domestic and international law enforcement, public safety, defense and intelligence agencies; real or perceived errors, failures, defects or bugs in our solutions; licensing of technology from third parties, including our dependence on maintaining those licenses or seeking alternative solutions; failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of our markets, including risks associated with pricing pressures from and loss of market share to competitors with greater resources than we have and increasing competition as a result of consolidation in the industry; the misuse of our solutions by our customers which may achieve suboptimal results or be perceived as incompatible with human rights; our ability to properly manage our growth as a business, and execute new offerings, developments and strategic opportunities, including joint ventures, partnerships and acquisitions; our dependence on our customers to renew their subscriptions and purchase additional subscriptions or services from us; conducting a low volume of our business via e-commerce; the use of artificial intelligence in our digital investigation platform; the availability of financing sources on reasonable terms or at all; our reliance on third-party suppliers for certain components, products or services, including risks relating to the availability of raw materials or components; challenges associated with large transactions, including with respect to longer sales cycles, as well as with developing, offering, implementing, and maintaining new solutions; risk of security vulnerabilities or defects, including cyber-attacks, information technology system breaches, failures or disruptions which are critical to our operations and maintaining the trust and confidence of our customers; risks associated with political, geo-political and reputational factors related to our business or operations, including Cellebrite operations in Israel and/or negative publicity, including with respect to the nature of our solutions; risks associated with our ability to obtain CFIUS approval for the acquisition of Corellium and with our ongoing compliance with national security agreements entered into with the U.S. government; risks that our intellectual property rights may not be adequate to protect our business or assets or that others may make claims on our intellectual property, claim infringement on their intellectual property rights, or claim a violation of their license rights, including relative to free or open-source-software components we may use risks relating to the regulatory constraints to which we are subject, including Israeli export laws, our compliance with such laws and related export licenses issued from the government of Israel; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer; risks associated with our significant international operations, including due to our Israeli operations, fluctuations in foreign exchange rates, rising global inflation, and exposure to regions subject to political or economic instability, including the State of Israel; uncertainties regarding the impact of changes in macroeconomic and/or global conditions, including as a result of slowdowns, recessions, economic instability, political unrest, or outbreaks of disease, as well as the resulting impact on information technology spending and government budgets, on our business and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”) on March 3, 2026, and in other documents filed by Cellebrite with the SEC, which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

About Cellebrite

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

Contacts:

Investors Relations

Andrew Kramer

Vice President, Investor Relations & Treasury

investors@cellebrite.com

+1 973.206.7760

Media

Jackie Labrecque

Director, PR and Executive Communications

jackie.labrecque@cellebrite.com  

+1 771.241.7010

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-initiates-plans-to-redomicile-in-the-united-states-302877229.html